Growth Metrics

Iterum Therapeutics (ITRM) Non-cash Items (2017 - 2022)

Historic Non-cash Items for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $1.1 million.

  • Iterum Therapeutics' Non-cash Items fell 9511.28% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $1.1 million, marking a year-over-year decrease of 9511.28%. This contributed to the annual value of $21.5 million for FY2021, which is 211865.98% up from last year.
  • Per Iterum Therapeutics' latest filing, its Non-cash Items stood at $1.1 million for Q3 2022, which was down 9511.28% from $4.0 million recorded in Q2 2022.
  • In the past 5 years, Iterum Therapeutics' Non-cash Items registered a high of $23.9 million during Q2 2021, and its lowest value of $78862.0 during Q3 2018.
  • In the last 5 years, Iterum Therapeutics' Non-cash Items had a median value of $1.1 million in 2022 and averaged $5.0 million.
  • As far as peak fluctuations go, Iterum Therapeutics' Non-cash Items skyrocketed by 460568.84% in 2019, and later tumbled by 9511.28% in 2022.
  • Iterum Therapeutics' Non-cash Items (Quarter) stood at $395000.0 in 2018, then tumbled by 35.7% to $254000.0 in 2019, then soared by 281.89% to $970000.0 in 2020, then skyrocketed by 2118.66% to $21.5 million in 2021, then plummeted by 94.92% to $1.1 million in 2022.
  • Its last three reported values are $1.1 million in Q3 2022, $4.0 million for Q2 2022, and $547583.0 during Q1 2022.